U.S. markets close in 6 hours 8 minutes
  • S&P 500

    4,267.26
    +25.42 (+0.60%)
     
  • Dow 30

    34,154.04
    +279.80 (+0.83%)
     
  • Nasdaq

    14,375.66
    +103.92 (+0.73%)
     
  • Russell 2000

    2,316.14
    +12.67 (+0.55%)
     
  • Crude Oil

    72.77
    -0.31 (-0.42%)
     
  • Gold

    1,784.80
    +1.40 (+0.08%)
     
  • Silver

    26.19
    +0.08 (+0.32%)
     
  • EUR/USD

    1.1952
    +0.0019 (+0.16%)
     
  • 10-Yr Bond

    1.4800
    -0.0070 (-0.47%)
     
  • GBP/USD

    1.3919
    -0.0045 (-0.32%)
     
  • USD/JPY

    110.7780
    -0.1840 (-0.17%)
     
  • BTC-USD

    33,932.80
    -256.15 (-0.75%)
     
  • CMC Crypto 200

    816.76
    +30.14 (+3.83%)
     
  • FTSE 100

    7,114.19
    +40.13 (+0.57%)
     
  • Nikkei 225

    28,875.23
    +0.34 (+0.00%)
     

Why Novavax Could Beat Moderna in Europe After Pfizer's Huge EU Vaccine Deal

·4 min read
Why Novavax Could Beat Moderna in Europe After Pfizer's Huge EU Vaccine Deal
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The European Commission president has provided some hints that a supply agreement with Novavax could be on the way.